Cantitate/Preț
Produs
Total produse
Vezi coșul
Myotonic Dystrophy: Present management, future therapy de Peter Harper

Myotonic Dystrophy: Present management, future therapy

Editat de Peter Harper, Baziel van Engelen, Bruno Eymard, Douglas Wilcox
en Limba Engleză Hardback – 15 ian 2004
This book provides a full and practical account of management of myotonic dystrophy, the commonest muscular dystrophy of adult life and a condition of exceptional variability.Written for neurologists, clinical geneticists and other clinical specialities involved with the disorder, it deals with both the neurological aspects and also the wide range of systemic complications that may occur. In addition it provides details of information and support available to patients and families and gives a summary of the present state of clinical trials of therapeutic agents. These sections are preceded by general introductory chapters describing both the clinical features and also the current state of research into understanding the underlying mechanisms.
Citește tot Restrânge

Preț: 182135 lei

Preț vechi: 246515 lei
-26%

Puncte Express: 2732

Carte tipărită la comandă

Livrare economică 03-08 decembrie

Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă

Specificații

ISBN-13: 9780198527824
ISBN-10: 0198527829
Pagini: 264
Ilustrații: numerous tables and figures
Dimensiuni: 161 x 241 x 19 mm
Greutate: 0.54 kg
Editura: OUP OXFORD
Colecția OUP Oxford
Locul publicării:Oxford, United Kingdom

Recenzii

The book is academically very good and written in a practical way that both patients and doctors will find useful...I can recommend the book, not only for patients but also for such doctors in general practice.
This book written by the main world experts in the field is a practical outline for both the clinicians and families. I strongly recommend it.
. . . illustrates all the various clinical aspects of this complex disease and gives insight into the pathogenesis and possibilities of the management of each complication at the different stages of myotonic dystrophy. The completeness of the data presented in each chapter is imporessive. The chapters are well structured and the illustrations are clear and informative. The flow charts are adequately structured and easy to understand. The references are well-selected and up-to-date. All chapters are written by renowned experts in the field of the myotonic dystrophies and neuromuscular diseases. It is a most educative book for clinicians working in the field of the neuromuscular diseases and for geneticists responsible for the genetic counselling of patients with myotonic dystrophy.
. . . a book that offers a wealth of up-to-date, practical and relevant information. Reflecting the central role of neuromuscular assessment and clinical management issues, this book is to be recommended as an essential reference for every neurologist involved in the care of patients with myotonic dystrophy.

Cuprins

  • Section 1 - Introduction: Clinical and biological basis of myotonic dystrophy
  • 1: Peter Harper: Myotonic dystrophy: a multi-systemic disorder
  • 2: Tetsua Ashizawa and Darren Monckton: Molecular aspects of myotonic dystrophy: our current understanding
  • Section 2 - Neuromuscular management of myotonic dystrophy
  • 3: Giovanni Meola and David Hilton-Jones: Diagnosis and baseline investigation: a core protocol
  • 4: Bruno Eymard and I Dobon: Missed diagnosis in myotonic dystrophy: frequency, characteristics, consequences, and how to prevent it
  • 5: Mark Rogers and Jean Mathieu: Follow up and assessment protocols for myotonic dystrophy
  • 6: Jean Mathieu and Margaret Phillips: Physical disability in myotonic dystrophy
  • Section 3 - Characterisation and management of systemic aspects
  • 7: Denis Duboc, Bruno Eymard and Maxwell Damian: Cardiac management of myotonic dystrophy
  • 8: Mark Rogers and Paul Clyburn: Anaesthesia and myotonic dystrophy
  • 9: Margaret Phillips: Respiratory problems in myotonic dystrophy and their management
  • 10: Baziel van Engelen and Han Brunner: Gastrointestinal dysfunction in myotonic dystrophy
  • 11: Asa Johannson and Tommy Olsson: Endocrine changes in myotonic dystrophy
  • 12: David Hilton-Jones, Maxwell Damian and Giovanni Meola: Somnolence and its management
  • Section 4 - Special aspects of management
  • 13: Sabine Rudnik and Christine de Die-Smulders: Pregnancy and perinatal problems in myotonic dystrophy
  • 14: Christine de Die-Smulders: Congenital and childhood-onset myotonic dystrophy
  • 15: Peter Harper and Han Brunner: Genetic counselling and genetic testing in myotonic dystrophy
  • Section 5 - Information and support
  • 16: Douglas Wilcox: Sharing information, knowledge and experience to build a team to help manage myotonic dystrophy
  • 17: Shannon Lord: Support groups for myotonic dystrophy and their role: an American family perspective
  • Section 6 - Therapeutic trials and future advances
  • 18: Charles Thornton, Richard Moxley and Robert Griggs: Therapeutic trials and future advances